HomeInsightsResults

Balaxi Pharmaceuticals Ltd Quarterly Result

Balaxi Pharmaceuticals Ltd Quarterly Result

stocks purchased

₹ 0.3 Cr

Volume Transacted

(Jan 8, 2025)

stocks purchased

36.9 K

Stocks Traded

(Jan 8, 2025)

Last Updated on: Jan 08, 2025

Image

Balaxi Pharmaceuticals Ltd

NSE: BALAXI

Net Profit - Last Quarter

₹ 4.59 Cr.

Last updated on: Jan 08, 2025

Key Highlights

  • The revenue of Balaxi Pharmaceuticals Ltd for the Sep '24 is ₹ 73.27 crore as compare to the Jun '24 revenue of ₹ 63.77 crore. This represent the growth of 14.897282%.
  • The ebitda of Balaxi Pharmaceuticals Ltd for the Sep '24 is ₹ 6.48 crore as compare to the Jun '24 ebitda of ₹ 8.24 crore. This represent the decline of -21.35922%.
  • The net profit of Balaxi Pharmaceuticals Ltd for the Sep '24 is ₹ 4.59 crore as compare to the Jun '24 net profit of ₹ 6.48 crore. This represent the decline of -29.166664%.

Results Analysis

Market Price of Balaxi Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Balaxi Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
07 Jan 202581.86
06 Jan 202578.69
03 Jan 202572.57
02 Jan 202573.64
01 Jan 202572
31 Dec 202472.31
30 Dec 202471.76
27 Dec 202470.12
26 Dec 202473.63
24 Dec 202475.06

Historical Revenue of Balaxi Pharmaceuticals Ltd

No data available

* All values are in crore

Historical EBITDA of Balaxi Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Balaxi Pharmaceuticals Ltd

No data available

* All values are in crore

Balaxi Pharmaceuticals Ltd News Hub

News

Balaxi Pharmaceuticals announces board meeting date

Balaxi Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 5 N...

Read more

30 Oct 2024 16:58

News

Balaxi Pharmaceuticals to conduct AGM

Balaxi Pharmaceuticals announced that the 81st Annual General Meeting(AGM) of the company ...

Read more

01 Aug 2024 12:52

News

Balaxi Pharmaceuticals to convene board meeting

Balaxi Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 2 A...

Read more

26 Jul 2024 10:45

News

Balaxi Pharma soars after expanding market presence in Angola & Latin America

In a regulatory filing made during market hours today, Balaxi Pharma stated that it has ha...

Read more

25 Jun 2024 12:14

News

Balaxi Pharmaceuticals to conduct board meeting

Balaxi Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 29 ...

Read more

24 May 2024 18:51

News

Balaxi Pharma edges higher after board approves stock split proposal

Accordingly, one equity share of the company, having face value of Rs 10 each, would be su...

Read more

28 Feb 2024 13:39

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for Quarterly Results of Balaxi Pharmaceuticals Ltd

What key financial metrics are included in Balaxi Pharmaceuticals Ltd's quarterly results?

Key financial metrics in Balaxi Pharmaceuticals Ltd's quarterly results typically include revenue, net profit, earnings per share (EPS), and operating margins. Other metrics might include cash flow, operating expenses, and client metrics.

When does Balaxi Pharmaceuticals Ltd announce its quarterly results?

Balaxi Pharmaceuticals Ltd usually announces its quarterly results around mid-July for Q1, mid-October for Q2, mid-January for Q3, and mid-April for Q4, aligning with the end of each fiscal quarter. However, different finance companies have their respective schedules for announcing their quarterly results.

How does Balaxi Pharmaceuticals Ltd's quarterly performance impact its stock price?

Balaxi Pharmaceuticals Ltd's quarterly performance can lead to stock price volatility, with strong results often driving the price up, while disappointing results can cause it to drop. Investor sentiment and market expectations also play significant roles.

What is the impact of Balaxi Pharmaceuticals Ltd's quarterly results on dividends?

The impact of Balaxi Pharmaceuticals Ltd's quarterly results on dividends can influence dividend decisions, with strong performance potentially leading to increased or special dividends, while weaker results might result in stable or reduced dividends.

Are there any special announcements usually made during Balaxi Pharmaceuticals Ltd's quarterly results?

Yes, Balaxi Pharmaceuticals Ltd often makes special announcements during its quarterly results, including strategic updates, key client wins, and major contract renewals. They might also guide future performance and share insights on industry trends. These updates are typically highlighted in their press release. However, special announcements made during quarterly results may vary from company to company.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions